查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
Humira 生物相似藥市場，按產品、適應症、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1358235

Humira 生物相似藥市場，按產品、適應症、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Humira Biosimilar Market, By Product, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年 Humira 生物相似藥市場規模為 7.901 億美元，2023 年至 2030 年複合年成長率為 20.9%

Humira 生物相似藥市場 - 市場動態：

  • 自體免疫疾病的盛行率不斷上升，對生物治療的需求不斷增加
  • 由於修美樂在某些地區的專利到期，修美樂生物相似藥市場正在經歷顯著成長，這使得其他製藥公司能夠進入該市場並生產更實惠的藥物版本。生物相似藥為參考藥物提供了具有成本效益的替代品，使患者更容易獲得治療並減少醫療支出。此外，自體免疫疾病的盛行率不斷上升以及對生物療法的需求不斷成長，也刺激了對 Humira 生物相似藥的需求。
  • 由於自體免疫疾病的發生率不斷增加以及隨後醫療保健支出的激增，在全球範圍內，研究和診斷機構正在參與與政府組織合作的舉措。美國國立衛生研究院 (NIH) 的資料顯示，自體免疫疾病位列女性死亡率升高的十大原因之一。因此，透過機構和政府機構之間的合作，正在共同努力應對這些健康挑戰。

Humira 生物相似藥市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，全球 Humira 生物相似藥市場預計在預測期內（2023-2030 年）每年將以 20.9% 左右的複合年成長率成長
  • 由於自體免疫疾病盛行率的增加以及對生物治療的需求不斷增加，修美樂生物相似藥產業預計將以顯著的速度成長
  • 根據適應症類型細分，預計類風濕關節炎將在 2022 年顯示最大的市場佔有率
  • 從產品細分來看，參考生物相似藥是2022年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

Humira 生物相似藥市場-細分分析：

  • 全球 Humira 生物相似藥市場根據產品、適應症和地區進行細分。
  • 市場根據產品分為三類：基於參考的生物相似藥、具有修飾胺基酸序列的生物相似藥和可互換的生物相似藥。預計到 2022 年，基於參考的生物相似藥領域將主導市場。基於參考的生物相似藥是透過直接將其特徵和性能與參考藥物修美樂（阿達木單抗）進行比較而開發的。它們是使用相似的細胞系和製程製造的，以生產高度相似的產品。
  • 市場依適應症分為四類：類風濕性關節炎、牛皮癬、克隆氏症等。類風濕性關節炎設備部門預計將佔收入的最大佔有率。類風濕性關節炎是一種自體免疫疾病，身體的免疫系統錯誤地攻擊滑膜，滑膜是關節周圍的膜內層。這會導致慢性炎症，導致關節損傷、疼痛、腫脹和僵硬。
  • 透過阻斷 TNF-α，阿達木單抗有助於減少發炎並減緩關節損傷的進展，從而緩解類風濕性關節炎的症狀並改善患者的生活品質。 Humira 生物相似藥用於治療類風濕性關節炎，因為它們含有與參考藥物 Humira（阿達木單抗）中的活性成分高度相似的版本。阿達木單抗是一種單株抗體，專門針對和抑制腫瘤壞死因子 α (TNF-α)，這種蛋白質在引起類風濕性關節炎關節發炎方面發揮關鍵作用。

Humira 生物相似藥市場 - 地理洞察：

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

Humira 生物相似藥市場-競爭格局：

Humira 生物相似藥市場的公司正在採取各種策略來獲得競爭優勢。其中包括投資於廣泛的研究和開發，以確保其生物相似藥的品質和功效，建立戰略夥伴關係或合作以利用互補的專業知識，以及擴大其地理分佈以進入新市場。此外，一些公司專注於提供有吸引力的定價模式和出色的售後支持，以吸引更多客戶並提高市場佔有率。

最近的發展：

2016 年 9 月，Amjevita（阿達木單抗-atto）成為 FDA 批准的第一個 Humira 生物相似藥。隨後，2023 年 1 月 31 日，它成為第一個在美國上市的 Humira 生物相似藥，標誌著另一個里程碑。 Amjevita 是已批准的 Humira 生物相似藥之一，已獲得監管部門批准用於治療成人 HS（化膿性汗腺炎）。

目錄

第 1 章：修美樂生物相似藥市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • Humira 生物相似藥市場片段（按產品）
    • Humira 生物相似藥市場片段（按適應症）
    • Humira 生物相似藥市場片段（按國家/地區）
    • Humira 生物相似藥市場片段（按地區）
  • 競爭洞察

第 3 章：修美樂生物相似藥主要市場趨勢

  • Humira 生物相似藥市場促進因素
    • 市場促進因素的影響分析
  • Humira 生物相似藥市場限制
    • 市場限制影響分析
  • Humira 生物相似藥市場機會
  • Humira 生物相似藥市場未來趨勢

第 4 章：修美樂生物相似藥產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：修美樂生物相似藥市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：修美樂生物相似藥市場格局

  • 2022 年 Humira 生物相似藥市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：修美樂生物相似藥市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 基於參考的生物相似藥
    • 具有修飾胺基酸序列的生物相似藥
    • 可互換的生物相似藥

第 8 章：Humira 生物相似藥市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 類風濕關節炎
    • 牛皮癬
    • 克隆氏症
    • 其他

第 9 章：Humira 生物相似藥市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • Humira 生物相似藥北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按指標）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • Humira 生物相似藥歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按產品）
    • 歐洲市場規模與預測（按指標）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • Humira 生物相似藥亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（依指標）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • Humira 生物相似藥拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按指標）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲修美樂生物類似藥主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（依指標）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - Humira 生物相似藥產業

  • 競爭儀表板
  • 公司簡介
    • Amgen
    • Samsung Bioepis
    • Sandoz (a division of Novartis)
    • Mylan (now part of Viatris)
    • Boehringer Ingelheim
    • Pfizer
    • Fresenius Kabi
    • Coherus BioSciences
    • Merck & Co.

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1743

REPORT HIGHLIGHT

Humira Biosimilar Market size was valued at USD 790.1 Million in 2022, expanding at a CAGR of 20.9% from 2023 to 2030

Humira biosimilars are biologic drugs that are highly similar to the reference biologic drug Humira (adalimumab). Adalimumab is a monoclonal antibody that targets tumor necrosis factor alpha (TNF-α) and is used to treat various autoimmune diseases, including rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Biosimilars are developed to be comparable in terms of safety, efficacy, and quality to the original drug but are manufactured by different companies after the patent of the reference drug has expired.

Humira Biosimilar Market - Market Dynamics:

  • Increasing prevalence of autoimmune diseases and the rising demand for biologic treatments
  • The Humira biosimilar market is experiencing significant growth due to the expiration of Humira's patents in certain regions, allowing other pharmaceutical companies to enter the market and produce more affordable versions of the drug. Biosimilars offer cost-effective alternatives to the reference drug, making treatment more accessible to patients and reducing healthcare expenditures. Additionally, the increasing prevalence of autoimmune diseases and the rising demand for biologic treatments have fueled the demand for Humira biosimilars.
  • Across the globe, research and diagnostic institutes are engaging in initiatives aligned with government organizations due to the increasing occurrence of autoimmune disorders and the subsequent surge in healthcare spending. The National Institutes of Health (NIH) data reveals that autoimmune disorders rank among the top ten causes of heightened mortality rates in women. As a result, concerted efforts are being made to address these health challenges through collaborative endeavors between institutes and government bodies.

Humira Biosimilar Market - Key Insights:

  • As per the analysis shared by our research analyst, the global Humira Biosimilar market is estimated to grow annually at a CAGR of around 20.9% over the forecast period (2023-2030)
  • The Humira Biosimilar industry is projected to grow at a significant rate due to increasing prevalence of autoimmune diseases and the rising demand for biologic treatments
  • Based on Indication type segmentation, Rheumatoid arthritis was predicted to show maximum market share in the year 2022
  • Based on Product segmentation, Reference-Based Biosimilars was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Humira Biosimilar Market- Segmentation Analysis:

  • The Global Humira Biosimilar Market is segmented on the basis of Product, Indication, and Region.
  • The market is divided into three categories based on Product: Reference-Based Biosimilars, Biosimilars with Modified Amino Acid Sequences and Interchangeable Biosimilars . In 2022, the Reference-Based Biosimilars segment is projected to dominate the market Reference-Based Biosimilars are developed by directly comparing their characteristics and performance to the reference drug, Humira (adalimumab). They are manufactured using similar cell lines and processes to produce a highly similar product.
  • The market is divided into four categories based on Indication: Rheumatoid arthritis, psoriasis, Crohn's disease and others. The Rheumatoid arthritis equipment segment is anticipated to hold the largest share in revenue. Rheumatoid arthritis is autoimmune disease in which the body's immune system mistakenly attacks the synovium, which is the lining of the membranes that surround the joints. This results in chronic inflammation, leading to joint damage, pain, swelling, and stiffness.
  • By blocking TNF-α, adalimumab helps to reduce inflammation and slow down the progression of joint damage, thereby providing relief from the symptoms of rheumatoid arthritis and improving the patient's quality of life. Humira biosimilars are used in the treatment of rheumatoid arthritis because they contain a highly similar version of the active ingredient found in the reference drug Humira (adalimumab). Adalimumab is a monoclonal antibody that specifically targets and inhibits tumor necrosis factor alpha (TNF-α), a protein that plays a key role in causing inflammation in the joints in rheumatoid arthritis.

Humira Biosimilar Market - Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Humira Biosimilar Market- Competitive Landscape:

Companies in the Humira biosimilar market are adopting various strategies to gain a competitive edge. These include investing in extensive research and development to ensure the quality and efficacy of their biosimilars, forming strategic partnerships or collaborations to leverage complementary expertise, and expanding their geographic presence to access new markets. Moreover, some companies focus on offering attractive pricing models and excellent after-sales support to attract more customers and enhance their market share.

Recent Developments:

In September 2016, Amjevita (adalimumab-atto) achieved the distinction of being the first FDA-approved biosimilar for Humira. Subsequently, on January 31, 2023, it marked another milestone by becoming the first Humira biosimilar to be launched in the United States. Amjevita is among the approved Humira biosimilars that have received regulatory clearance for treating HS (hidradenitis suppurativa) in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMIRA BIOSIMILAR MARKET KEY PLAYERS

  • Amgen
  • Samsung Bioepis
  • Sandoz (a division of Novartis)
  • Mylan (now part of Viatris)
  • Boehringer Ingelheim
  • Pfizer
  • Fresenius Kabi
  • Coherus BioSciences
  • Merck & Co.

GLOBAL HUMIRA BIOSIMILAR MARKET, BY PRODUCT

  • Reference-Based Biosimilars
  • Biosimilars with Modified Amino Acid Sequences
  • Interchangeable Biosimilars

GLOBAL HUMIRA BIOSIMILAR MARKET, BY INDICATION

  • Rheumatoid arthritis
  • Psoriasis
  • Crohn's disease
  • Others

GLOBAL HUMIRA BIOSIMILAR MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Humira Biosimilar Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Humira Biosimilar Market Snippet by Product
    • 2.1.2. Humira Biosimilar Market Snippet by Indication
    • 2.1.3. Humira Biosimilar Market Snippet by Country
    • 2.1.4. Humira Biosimilar Market Snippet by Region
  • 2.2. Competitive Insights

3. Humira Biosimilar Key Market Trends

  • 3.1. Humira Biosimilar Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Humira Biosimilar Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Humira Biosimilar Market Opportunities
  • 3.4. Humira Biosimilar Market Future Trends

4. Humira Biosimilar Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Humira Biosimilar Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Humira Biosimilar Market Landscape

  • 6.1. Humira Biosimilar Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Humira Biosimilar Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 7.1.2. Reference-Based Biosimilars
    • 7.1.3. Biosimilars with Modified Amino Acid Sequences
    • 7.1.4. Interchangeable Biosimilars

8. Humira Biosimilar Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Rheumatoid arthritis
    • 8.1.3. Psoriasis
    • 8.1.4. Crohn's disease
    • 8.1.5. Others

9. Humira Biosimilar Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Humira Biosimilar Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Humira Biosimilar Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Humira Biosimilar Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Humira Biosimilar Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Humira Biosimilar Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Humira Biosimilar Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Amgen
    • 10.2.2. Samsung Bioepis
    • 10.2.3. Sandoz (a division of Novartis)
    • 10.2.4. Mylan (now part of Viatris)
    • 10.2.5. Boehringer Ingelheim
    • 10.2.6. Pfizer
    • 10.2.7. Fresenius Kabi
    • 10.2.8. Coherus BioSciences
    • 10.2.9. Merck & Co.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Humira Biosimilar Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Humira Biosimilar Market, by Product 2018-2030 (USD Million)
  • TABLE Humira Biosimilar Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Humira Biosimilar Market, by Indication 2018-2030 (USD Million)
  • TABLE Humira Biosimilar Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Humira Biosimilar Market, by Region 2018-2030 (USD Million)
  • TABLE North America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Humira Biosimilar Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Humira Biosimilar Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Humira Biosimilar Market, by Indication, 2018-2030 (USD Million)

List of Figures

  • FIGURE Humira Biosimilar Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Humira Biosimilar Market share and leading players, 2022
  • FIGURE Europe Humira Biosimilar Market share and leading players, 2022
  • FIGURE Asia Pacific Humira Biosimilar Market share and leading players, 2022
  • FIGURE Latin America Humira Biosimilar Market share and leading players, 2022
  • FIGURE Middle East and Africa Humira Biosimilar Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Humira Biosimilar Market share analysis by country, 2022
  • FIGURE Germany Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Humira Biosimilar Market share analysis by country, 2022
  • FIGURE India Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Humira Biosimilar Market share analysis by country, 2022
  • FIGURE Brazil Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Humira Biosimilar Market share analysis by country, 2022
  • FIGURE Saudi Arabia Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Humira Biosimilar Market size, forecast and trend analysis, 2018 to 2030 (USD Million)